Jupiter Investment Management’s Trueblue TBI Stock Holding History

Jupiter Investment Management’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-249	Closed	-$6K	–	449
2017 Q2	$6K	Buy	+249	New	+$6.64K	﹤0.01%	393

Other funds holding TBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Jupiter Investment Management's TBI Position: Q3 2017 in Review

Jupiter Investment Management sold out of Trueblue (TBI) in Q3 2017, closing a stake of 249 shares — an estimated $6K sold.

Jupiter Investment Management first reported a position in TBI in Q2 2017 and held it in 1 quarter. The position peaked at $6K in Q2 2017. 191 funds tracked by Wall St. Rank hold TBI as of Q3 2017.

Jupiter Investment Management reported no remaining Trueblue position as of Q3 2017 after selling out during the quarter.
Jupiter Investment Management sold 249 Trueblue shares in Q3 2017, an estimated $6K.
Jupiter Investment Management first reported a position in Trueblue in Q2 2017 and held it in 1 quarter.
Jupiter Investment Management's Trueblue position peaked at $6K in Q2 2017.
191 funds tracked by Wall St. Rank held Trueblue as of Q3 2017.

Based on Jupiter Investment Management's 13F filing for Q3 2017, filed 1 Nov 2017.